BioCentury | Mar 27, 2019
Financial News

NASH company Genfit gains dual listing via NASDAQ offering

...Partners and H.C. Wainwright are underwriting the NASDAQ offering as well, while Bryan Garnier and Natixis...
BioCentury | Mar 15, 2019
Financial News

Sanofi raises €2B via bond issue

...billion ($2.2 billion) through the sale of fixed rate notes. Underwriters were BofA Merrill Lynch, Natixis...
BioCentury | Mar 1, 2019
Financial News

Genfit files for NASDAQ listing

...€207.2 million ($236.9 million) in cash at YE18. Underwriters are SVB Leerink, Barclays, Bryan Garnier, Natixis...
BioCentury | Feb 28, 2019
Financial News

Genfit files for NASDAQ listing

...€207.2 million ($236.9 million) in cash at YE18. Underwriters are SVB Leerink, Barclays, Bryan Garnier, Natixis...
BioCentury | Oct 13, 2017
Financial News

Genfit raises EUR180M via bond issue

...$211.1 million) through the sale of convertible bonds in a private placement. Kepler Chevreux and Natixis...
BioCentury | Oct 11, 2017
Financial News

Genfit raises €180M via bond issue

...$211.1 million) through the sale of convertible bonds in a private placement. Kepler Chevreux and Natixis...
BioCentury | Nov 3, 2016
Financial News

Genfit completes rights offering

...sale of 3.1 million shares at €14.30 in a rights offering underwritten by Citigroup and Natixis...
BioCentury | Oct 31, 2016
Financial News

Genfit tops off funding with EUR 44.6M offering

...3.1 million shares at EUR 14.30 in an oversubscribed rights offering underwritten by Citigroup and Natixis...
BioCentury | Nov 24, 2014
Financial News

Onxeo proposes rights offering

...prior: 31.5 million Investors: Financiere de la Montagne; Nyenburgh; Capital Ventures International; existing investors Underwriters: Natixis...
BioCentury | Nov 19, 2014
Financial News

Onxeo proposes EUR 35.4M rights offering

...Euronext:ONXEO) proposed to raise EUR 35.4 million ($44.1 million) in a rights offering underwritten by Natixis...
Items per page:
1 - 10 of 53
BioCentury | Mar 27, 2019
Financial News

NASH company Genfit gains dual listing via NASDAQ offering

...Partners and H.C. Wainwright are underwriting the NASDAQ offering as well, while Bryan Garnier and Natixis...
BioCentury | Mar 15, 2019
Financial News

Sanofi raises €2B via bond issue

...billion ($2.2 billion) through the sale of fixed rate notes. Underwriters were BofA Merrill Lynch, Natixis...
BioCentury | Mar 1, 2019
Financial News

Genfit files for NASDAQ listing

...€207.2 million ($236.9 million) in cash at YE18. Underwriters are SVB Leerink, Barclays, Bryan Garnier, Natixis...
BioCentury | Feb 28, 2019
Financial News

Genfit files for NASDAQ listing

...€207.2 million ($236.9 million) in cash at YE18. Underwriters are SVB Leerink, Barclays, Bryan Garnier, Natixis...
BioCentury | Oct 13, 2017
Financial News

Genfit raises EUR180M via bond issue

...$211.1 million) through the sale of convertible bonds in a private placement. Kepler Chevreux and Natixis...
BioCentury | Oct 11, 2017
Financial News

Genfit raises €180M via bond issue

...$211.1 million) through the sale of convertible bonds in a private placement. Kepler Chevreux and Natixis...
BioCentury | Nov 3, 2016
Financial News

Genfit completes rights offering

...sale of 3.1 million shares at €14.30 in a rights offering underwritten by Citigroup and Natixis...
BioCentury | Oct 31, 2016
Financial News

Genfit tops off funding with EUR 44.6M offering

...3.1 million shares at EUR 14.30 in an oversubscribed rights offering underwritten by Citigroup and Natixis...
BioCentury | Nov 24, 2014
Financial News

Onxeo proposes rights offering

...prior: 31.5 million Investors: Financiere de la Montagne; Nyenburgh; Capital Ventures International; existing investors Underwriters: Natixis...
BioCentury | Nov 19, 2014
Financial News

Onxeo proposes EUR 35.4M rights offering

...Euronext:ONXEO) proposed to raise EUR 35.4 million ($44.1 million) in a rights offering underwritten by Natixis...
Items per page:
1 - 10 of 53